Mat***luk
Education
Carnegie Mellon University - Tepper School of Business (2006 - 2008)
- Degree: MBA
- Field of Study: Entrepreneurship, Finance, Marketing, Strategy
- Description: William G. McGowan Scholar, James R. Swartz Entrepreneurial Fellow, Tepper School of Business Merit Scholarship Recipient, Walter Rittman Endowed Scholar
University of Pittsburgh School of Medicine (Unknown - 2006)
- Degree: PhD
- Field of Study: Cell Biology, Biochemistry
- Description: Dissertation: Protein Interaction Domains in Clathrin-Mediated Endocytosis.
University of Notre Dame (Unknown - Present)
- Degree: BS
- Field of Study: Biochemistry
- Description:
Skills:
Business Development, Strategy, Biotechnology, Product Management
Work Experience:
Chief Business Officer at AIRNA
- Location:
- Duration: 2025-01 to Present
- Description:
Director, Board of Directors at OUROTECH, INC. (D.B.A. PEAR BIO)
- Location: London, United Kingdom
- Duration: 2024-07 to Present
- Description:
Director, Board of Directors at Predictive Oncology
- Location:
- Duration: 2022-11 to Present
- Description:
Advisory Board Member at PathAI
- Location: Boston, Massachusetts, United States
- Duration: 2020-03 to Present
- Description:
EVP, Chief Business Officer & Boston Site Head at Gritstone bio
- Location: Cambridge, MA
- Duration: 2015-11 to 2025-01
- Description: Executive Vice President and Chief Business Officer, 1/2015 – Present Head of Legal, 9/2022 – Present Boston Site Head (Previously Cambridge, MA), 7/2021 – Present Led several pivotal deals w/ Government and non-government partners • BARDA project and submission of Broad Agency Announcement application including Technical and Cost Volumes and negotiation of the contract to conduct a comparative 10,000 subject Phase 2b clinical trial evaluating a next-generation vaccine candidate for COVID-19 with funding valued up to $433M (Sep’23) • Collaboration, Option and License agreement with Gilead Sciences to research and develop an HIV cure (Jan’21), utilizing Gritstone technology for Gilead’s development and commercialization. Total deal value of $785M with $60M upfront • Research collaboration and license agreement with bluebird bio (now 2seventy bio) whereby Gritstone provides tumor-specific targets and TCRs for cell therapy (Aug’18). Total deal value of $1.2B with $20M upfront cash and $20M in equity ($10M in Series C and $10M in IPO) • Grant agreements with Bill & Melinda Gates Foundation funding for an optimal immunogen for HPV eradication ($3.2M) and for a next-generation SARS-CoV-2 vaccine ($575K) • Funding agreement with the Coalition for Epidemic Preparedness Innovations (CEPI) to advance a second-generation samRNA SARS-CoV-2 vaccine in South Africa. Funding up to $25.6M for a multi-arm Phase 1 study, preclinical studies, and scale-up, and formulation development
Candidate Intelligence Report
AI-powered analysis from the perspective of a US hiring director — evaluating career continuity, growth trajectory, and role fit.
Career Continuity & Risk Assessment
No gaps in employment are evident; the candidate has maintained continuous work in senior biotech leadership and advisory roles since 2015.
Career across biotechnology, biopharma, and life sciences partnerships is highly consistent with educational background and skill set.
A long tenure at Gritstone (2015–2025) demonstrates stability; subsequent transitions to AIRNA and ongoing governance roles are typical for senior biotech executives and not indicative of instability.
CMU Tepper School of Business credentials align with C-suite BD/strategy roles in biotech, supporting a strong education-career fit.
Career Growth Curve
Best-Fit Roles (Top 5)
Chief Executive Officer (CEO)97% fit
Proven P&L leadership, extensive deal-making at scale (e.g., HIV cure collaboration, COVID-19 vaccines), and multi-board governance experience, all of which align with steering a biotech company toward growth and commercialization milestones.
Chief Commercial Officer (CCO) / Chief Business Officer (CBO)92% fit
Direct alignment with a decade of business development and strategic partnerships, including major industry deals and government collaborations; strong network across pharma and biotech partners.
Chief Strategy Officer (CSO) / Head of Corporate Development90% fit
Expertise in formulating growth strategies and negotiating high-value collaborations; well-suited to align product portfolios with market opportunities and corporate strategy.
Non-Executive Director (Board Director) – Life Sciences85% fit
Extensive board governance experience across multiple biotech entities; brings risk oversight, strategic judgment, and stakeholder management to boards.
Senior Vice President, Corporate Development82% fit
Deep experience in licensing, collaborations, and strategic partnerships; ideal for driving growth initiatives within a larger biopharma/biotech organization.
Related Sourcing Channels
Groups and Events where you can find more candidates with similar skills and background.
Experience AI Recruiter
$0 to start. Don't let your competitors get the AI advantage first.
Join over 10,000 companies using AI-driven recruitment solutions to automate your hiring process and save 80% in time costs.
24/7 automated operation
AI-powered candidate screening
Recruitment without geographical or time zone limitations
Personalized intelligent communication
Automated assessment of candidate engagement
Intelligently mimics and replicates your recruitment style
4-month money-back guarantee
Ensures LinkedIn account security
©Strategybrain Technology Ltd.
info@strategybrain.ca